Drug · DIN 02375192
Q-SUMATRIPTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 21, 2015.
- Drug Identification Number (DIN)
- 02375192
- Company (DIN owner)
- Qd Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 6, 2011: NOC 12848Abbreviated New Drug Submission (ANDS) · New Manufacturer and Product Name
Other DINs named Q-SUMATRIPTAN
- DIN 02375184 · Cancelled Pre Market
- DIN 02375206 · Cancelled Pre Market